is an Intellectual Property associate in Troutman Pepper’s Atlanta office and uses her technical background to help clients with all areas of intellectual property law. She draws on her education and experience to provide services in connection with a broad range of technologies, including consumer goods, software and biomedical devices.
Scientists, engineers, and everyday people have developed solutions for testing, preventing, and treating the COVID-19 disease. Ordinarily, we wouldn’t think twice about granting patents on these inventions. But, today, when COVID-19 is spreading all over the world and killing millions of people, some world leaders are questioning whether we should be granting the exclusionary rights of patent protection on inventions that help respond to the pandemic. Included in that group is the Biden-Harris Administration, which, in May, announced their support of an “IP waiver” on COVID 19 vaccines.